Subcutaneous immunoglobulin 20% (Ig20Gly) treatment regimens in pediatric patients with primary immunodeficiencies - real-world data from the IG TATRY study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Edyta,Heropolitańska-Pliszka

第一单位： Department of Immunology, Children's Memorial Health Institute, Warsaw, Poland.

作者： Edyta,Heropolitańska-Pliszka ^[1] ; Małgorzata,Pac ^[1] ; Barbara,Pietrucha ^[1] ; Edyta,Machura ^[2] ; Anna,Pukas-Bochenek ^[2] ; Ewelina,Chrobak ^[2] ; Ewa,Bień ^[3] ; Magdalena,Malanowska ^[3] ; Anna,Pituch-Noworolska ^[4] ; Szymon,Drygała ^[5] ; Marta,Kamieniak ^[6] ; Jakub,Kasprzak ^[5] ; Monika,Mach-Tomalska ^[4]

作者单位： Department of Immunology, Children's Memorial Health Institute, Warsaw, Poland. ^[1] Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Zabrze, Poland. ^[2] Department of Pediatrics, Hematology and Oncology, Medical University of Gdansk, Gdansk, Poland. ^[3] Department of Immunology, University Children's Hospital of Cracow, Cracow, Poland. ^[4] Takeda Pharma Sp. Z.O.o, Medical Affairs, Warsaw, Poland. ^[5] Takeda Development Center Americas, Inc, Cambridge, MA, USA. ^[6]

关键词 IG-TATRY study Subcutaneous immunoglobulin infusion pediatric population primary immunodeficiency diseases real-world data

主题词儿童(Child);人类(Humans);回顾性研究(Retrospective Studies);免疫缺陷综合征(Immunologic Deficiency Syndromes);免疫球蛋白G(Immunoglobulin G);注射, 皮下(Injections, Subcutaneous);临床方案(Clinical Protocols);免疫球蛋白类, 静脉内(Immunoglobulins, Intravenous);输注, 皮下(Infusions, Subcutaneous)

DOI 10.1080/1744666X.2023.2240514

PMID 37489744

发布时间 2023-11-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Expert review of clinical immunology

1281-1291页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Subcutaneous immunoglobulin 20% (Ig20Gly) treatment regimens in pediatric patients with primary immunodeficiencies - real-world data from the IG TATRY study.

Expert review of clinical immunology

相似文献

Expert review of clinical immunology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Subcutaneous immunoglobulin 20% (Ig20Gly) treatment regimens in pediatric patients with primary immunodeficiencies - real-world data from the IG TATRY study.

Expert review of clinical immunology

相似文献

Expert review of clinical immunology

相关期刊

检索历史清除